Guilford, CT, United States of America

Mae R Gailani

Average Co-Inventor Count = 22.0

ph-index = 1

Forward Citations = 11(Granted Patents)

Forward Citations (Not Self Cited) = 11(Sep 21, 2024)


Years Active: 2003-2008

where 'Filed Patents' based on already Granted Patents

2 patents (USPTO):

Title: Inventor Mae R. Gailani: Pioneering Tumor Suppressor Gene Innovations

Introduction

Mae R. Gailani is a prominent inventor based in Guilford, Connecticut. She is known for her significant contributions to medical research, particularly in the field of gene therapy related to cancer. With two patents to her name, her work focuses on tumor suppressor genes and their implications in treating certain types of cancer, especially basal cell carcinoma.

Latest Patents

Mae R. Gailani's latest patents are crucial advancements in understanding genetic factors related to cancer. One of her patents addresses the inactivation of a tumor suppressor gene that is a causal factor in nevoid basal cell carcinoma syndrome and various sporadic basal cell carcinomas. This invention particularly highlights the NBCCS gene, which is a homologue of the patched (ptc) gene. Such discoveries are instrumental in developing targeted therapies for patients suffering from these conditions.

Another patent by Mae further explores the same themes, emphasizing the importance of the tumor suppressor gene within the realm of cancer research. Both patents reflect her dedication to advancing medical science and improving treatment options for patients with genetic predispositions to cancer.

Career Highlights

Mae R. Gailani works with the United States of America as represented by the Secretary of the Department of Health and Human Services. Through her role, she has contributed to significant research and the development of innovations that aim to combat cancer. Her dedication to her work has earned her a reputation as a leading figure in tumor suppressor gene research.

Collaborations

Throughout her career, Mae has collaborated with esteemed professionals in the field, including notable coworkers such as Michael C. Dean and Heidi Eve Hahn. These collaborations have not only enhanced her research but have also fostered a community of innovation that drives medical advancements forward.

Conclusion

Mae R. Gailani stands out as an influential inventor with a focus on critical innovations in cancer research. Her work on tumor suppressor genes is paving the way for new therapeutic approaches, providing hope for many patients affected by basal cell carcinoma. The contributions of inventors like Mae are vital to medical progress, showcasing the importance of innovation in improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…